The risk of second primary tumors after resection of stage I nonsmall cell lung cancer David Rice, MB, BCh, Hyung-Woo Kim, MS, Anita Sabichi, MD, Scott.

Slides:

Advertisements

Similar presentations

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution Linda W. Martin, MD, Arlene.

Advertisements

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 Antonio L Visbal, MD, Brent.

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

Thomas J. Birdas, MD, Richard P. M

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema Eugenio Pompeo, MD, Enrico De Dominicis,

Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer Stephen G. Swisher, MD, Mary Maish, MD, Jeremy J. Erasmus, MD, Arlene.

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Puja Gaur, MD, Wayne L. Hofstetter, MD, B

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population Edmund S. Kassis, MD, Ara A. Vaporciyan,

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion Sunil Gandhi, MD, Garrett L Walsh, MD, Ritsuko Komaki, MD, Ziya.

Andrew D. Shaw, MB, Ara A. Vaporciyan, MD, Xifeng Wu, MD, Terri M

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy Apar Pataer, MD, PhD, Neda Kalhor,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Tina Cascone, MD, PhD, Kathryn A. Gold, MD, Stephen G

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Membrane Carbonic Anhydrase IX Expression and Relapse Risk in Resected Stage I–II Non–Small-Cell Lung Cancer David J. Stewart, MD, Maria I. Nunez, MD,

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Relationship Between Tumor Size and Survival in Non–Small-Cell Lung Cancer (NSCLC): An Analysis of the Surveillance, Epidemiology, and End Results (SEER)

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

David C. Rice, MB, BCh, Matthew A

Surgical Treatment of Metachronous Second Primary Lung Cancer

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,

Andrea S. Wolf, MD, MPH, Scott J

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Telomere Length and Recurrence Risk after Curative Resection in Patients with Early- Stage Non–Small-Cell Lung Cancer: A Prospective Cohort Study Eric.

Anthony J. Ascioti, MD, Wayne L. Hofstetter, MD, Michael J

Thomas J. Birdas, MD, Richard P. M

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy Arya Amini, BA, Arlene.

Prognostic factors in clinical stage I non–small cell lung cancer

Repke J Snijder, Aart Brutel de la Rivière, Hans J. J Elbers, Jules M

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, MB, BCh, Craig.

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Robert R. McMillan, MD, MPH, Camelia S. Sima, MD, MS, Nicole H

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Pulmonary Resection for Lung Cancer in Octogenarians

Journal of Thoracic Oncology

Anne S. Tsao, MD, Suyu Liu, PhD, J. Jack Lee, PhD, Christine M

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Management of Primary Pulmonary Artery Sarcomas

David C. Rice, MB, BCh, Jeremy J. Erasmus, MD, Craig W

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD,

Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma Chang Hyun Kang, MD, PhD, Yoohwa Hwang, MD,

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Mara B. Antonoff, MD, Wayne L. Hofstetter, MD, Arlene M

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter Joe B Putnam, MD, Garrett L Walsh, MD, Stephen G Swisher,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer Stephen G. Swisher, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Arlene.

Jenifer L. Marks, MD, Wayne Hofstetter, MD, Arlene M

Presentation transcript:

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer David Rice, MB, BCh, Hyung-Woo Kim, MS, Anita Sabichi, MD, Scott Lippman, MD, J.Jack Lee, PhD, Brendell Williams, RN, Ara Vaporciyan, MD, W.Roy Smythe, MD, Stephen Swisher, MD, Garrett Walsh, MD, Joe B Putnam, MD, Waun Ki Hong, MD, Jack Roth, MD The Annals of Thoracic Surgery Volume 76, Issue 4, Pages 1001-1008 (October 2003) DOI: 10.1016/S0003-4975(03)00821-X

Fig 1 Cumulative incidence of second primary lung cancer (SPLC) after resection of initial primary tumor. (Dashed lines = 95% confidence interval.) The Annals of Thoracic Surgery 2003 76, 1001-1008DOI: (10.1016/S0003-4975(03)00821-X)

Fig 2 Effect of smoking status on cumulative incidence of second primary lung cancer (SPLC), p = 0.01. Solid line = current (n = 230); broken line = former (n = 295); dashed line = never (n = 44). The Annals of Thoracic Surgery 2003 76, 1001-1008DOI: (10.1016/S0003-4975(03)00821-X)

Fig 3 Actuarial survival of 569 patients after resection of stage I nonsmall cell lung cancer, p = 0.0001. Dashed line = others (n = 362); broken line = non–lung second primary tumor (n = 39); solid line = second primary lung cancer (n = 49); dotted line = recurrence (n = 119). The Annals of Thoracic Surgery 2003 76, 1001-1008DOI: (10.1016/S0003-4975(03)00821-X)